Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
23.54
+0.99 (4.39%)
At close: Oct 15, 2026, 4:00 PM EDT
23.00
-0.54 (-2.29%)
After-hours: Oct 15, 2026, 7:30 PM EDT
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $1.37B in the quarter ending June 30, 2026, with 10.23% growth. This brings the company's revenue in the last twelve months to $5.02B, up 11.95% year-over-year. In the year 2025, Elanco Animal Health had annual revenue of $4.72B with 6.22% growth. That makes Elanco Animal Health the 2,594th largest company in the world by revenue and 746th in the United States.
Revenue (ttm)
$5.02B
Revenue Growth
+11.95%
P/S Ratio
2.34
Revenue / Employee
$507,071
Employees
9,900
Market Cap
11.76B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.72B | 276.00M | 6.22% |
| Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
| Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
| Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
| Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
| Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
| Dec 31, 2019 | 3.07B | 4.20M | 0.14% |
| Dec 31, 2018 | 3.07B | 177.80M | 6.15% |
| Dec 31, 2017 | 2.89B | -24.50M | -0.84% |
| Dec 31, 2016 | 2.91B | 4.40M | 0.15% |
| Dec 31, 2015 | 2.91B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Viatris | 14.74B |
| Dr. Reddy's Laboratories | 3.50B |
| Neurocrine Biosciences | 3.37B |
| United Therapeutics | 3.15B |
| Amneal Pharmaceuticals | 3.12B |
| Hims & Hers Health | 2.58B |
| Alkermes | 1.67B |
| Lantheus Holdings | 1.56B |
ELAN News
- 7 days ago - What Growing Up on a Farm Taught Elanco's CEO - WSJ
- 23 days ago - Elanco Animal Health Transcript: Bank of America Global Healthcare Conference - Transcripts
- 4 weeks ago - Elanco to Participate in BofA Securities Global Healthcare Conference 2026 - PRNewsWire
- 4 weeks ago - Elanco Animal Health Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care - PRNewsWire
- 4 weeks ago - Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement - PRNewsWire
- 5 weeks ago - Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference - PRNewsWire
- 7 weeks ago - Elanco announces completion of manufacturing expansion at Elwood - TheFly